Epstein Secrets

ctious Diseases, Weill Medic=l College of Cornell University, New York, NY 2. Department of Microbiology and Immunology, Weill Medical College of C=rnell University, New York, NY 3. United States Army Medical Research Institute of Infectious Diseases= Frederick, MD. 4. Integrated Research Facility, Division of

sequencing. Earlier this year, I receiv=d the IFCC Award for Significant Contributions in Molecular Diagnostic=. I have been collaborating with Dr. Linnie Golightly of our Center for G=obal Health/Infectious Disease Division for the past decade, work=ng together closely to develop multiplexed PCR-LDR assays for

rone D.H.2, 6= Spitzer E.D.7, Barany F.2 and Golightly L.M.1, 2 1. Department of Medicine, Division of Infectious Diseases, Weill Medi=al College of Cornell University, New York, NY 2. Department of Microbiology and Immunology, Weill Medical College of=Cornell University, New York, NY 3. United States Army Medica

sequencing. Earlier this year, I re=eived the IFCC Award for Significant Contributions in Molecular Diagn=stics. I have been collaborating with Dr. Linnie Golightly of our Center for =lobal Health/Infectious Disease Division for the past decade, wo=king together closely to develop multiplexed PCR-LDR assays for

Diseases, Centers for Disease Control and Prevention,&nbs=;Atlanta, GA 6. Department of Pathology and Laboratory Medicine, Weill Medical Colle=e of Cornell University, New York, NY 7. Department of Pathology, Stony Brook University Medical Center, Ston= Brook, NY ABSTRACT CDC designated category A infectious age

sequencing. Earlier this year, I receiv=d the IFCC Award for Significant Contributions in Molecular Diagnostic=. I have been collaborating with Dr. Linnie Golightly of our Center for G=obal Health/Infectious Disease Division for the past decade, work=ng together closely to develop multiplexed PCR-LDR assays for